|
Endocrine,
Metabolic & Immune Disorders - Drug Targets
(Formerly 'Current Drug Targets - Immune, Endocrine &
Metabolic Disorders')
ISSN: 1871-5303 - Volume 10, 4 Issues, 2010
Aims & Scope
This journal is devoted to timely reviews
of experimental and clinical studies in the field of endocrine,
metabolic, and immune disorders. Specific emphasis is placed
on humoral and cellular targets for natural, synthetic, and
genetically engineered drugs that enhance or impair endocrine,
metabolic, and immune parameters and functions. Topics related
to the neuroendocrine-immune axis are given special emphasis
in view of the growing interest in stress-related, inflammatory,
autoimmune, and degenerative disorders. Original articles
related to Immune Disorders and Drug Targeting are also considered
for publication
Indexed in:
Chemical Abstracts, BIOSIS, MEDLINE, EMBASE, BIOSIS Previews,
BIOSIS Reviews Reports and Meetings, Google, Google Scholar,
Genamics JournalSeek, MediaFinder®-Standard
Periodical Directory, Scopus
You may also be interested in:
SUBSCRIPTION
BASED JOURNALS
Current
Immunology Reviews
Immunology
Endocrine and Metabolic Agents in Medicinal Chemistry
Current
Diabetes Reviews
Current
Pharmaceutical Design
BENTHAM
OPEN JOURNALS
EBOOKS
Soluble
Factors Mediating Innate Immune Responses to HIV Infection
Microcirculation
and Insulin Resistance
Hypercalcemia
Pathophysiology & Treatment
Emerging
Chagas Disease
Protein
Misfolding Disorders: A Trip into the ER
Frontiers
in Drug Design and Discovery
|
.gif)
